Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
47
Employees47
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
47
Employees47

LGND Key Statistics

Market cap
4.19B
Market cap4.19B
Price-Earnings ratio
34.41
Price-Earnings ratio34.41
Dividend yield
Dividend yield
Average volume
267.84K
Average volume267.84K
High today
$213.21
High today$213.21
Low today
$201.94
Low today$201.94
Open price
$209.83
Open price$209.83
Volume
38.93K
Volume38.93K
52 Week high
$227.92
52 Week high$227.92
52 Week low
$93.58
52 Week low$93.58

Stock Snapshot

With a market cap of 4.19B, Ligand Pharmaceuticals(LGND) trades at $210.00. The stock has a price-to-earnings ratio of 34.41.

During the trading session on 2026-03-18, Ligand Pharmaceuticals(LGND) shares reached a daily high of $213.21 and a low of $201.94. At a current price of $210.00, the stock is +4.0% higher than the low and still -1.5% under the high.

Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 38.93K, versus its average volume of 267.84K.

Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $227.92 and a low of $93.58.

Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $227.92 and a low of $93.58.

LGND News

Simply Wall St 4d
Fresh Analyst Coverage Puts Ligand Pharmaceuticals Royalty Model And Valuation In The Spotlight

Advertisement Why fresh analyst coverage matters for Ligand Pharmaceuticals (LGND) Recent coverage initiations from Bank of America Securities and other firms...

Fresh Analyst Coverage Puts Ligand Pharmaceuticals Royalty Model And Valuation In The Spotlight
Benzinga 7d
Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst

Bank of America (BofA) Securities on Wednesday initiated coverage on Ligand Pharmaceuticals Inc (NASDAQ:LGND) , citing the distinctive royalty firm offers compe...

Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.